Generic dry powder inhalers bioequivalence: Batch-to-batch variability insights.

Drug Discov Today

Respiratory Technology Group, Woolcock Institute of Medical Research, Glebe 2037, NSW, Australia; Macquarie Business School, Macquarie University 2109, NSW, Australia.

Published: November 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Active pharmaceutical ingredient(s) [API(s)] of dry powder inhalers (DPIs) deposition and their fate in the respiratory system are influenced by a complex matrix of formulation, device, manufacturing and physiological variations. DPIs on the market have shown bioinequivalence between batches of the same product. Despite being clinically insignificant, they affect bioequivalence studies when a generic product is compared with the originator. This review discusses implications of batch-to-batch variability on bioequivalence study outcomes and shortcomings of current regulatory requirements. Possible formulation and manufacturing factors resulting in batch-to-batch variability highlight the inherent nature of this issue. Despite scholarly investigations and official regulatory guidance, there remains a need for reliable and realistic in vitro tests that accurately guide a representative reference product batch selection.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drudis.2022.103350DOI Listing

Publication Analysis

Top Keywords

batch-to-batch variability
12
dry powder
8
powder inhalers
8
generic dry
4
inhalers bioequivalence
4
bioequivalence batch-to-batch
4
variability insights
4
insights active
4
active pharmaceutical
4
pharmaceutical ingredients
4

Similar Publications

Mesenchymal stem/stromal cells (MSCs) have been identified as a promising therapeutic option for osteoarthritis, graft vs. host disease and cardiovascular diseases, among others. For widespread application of these therapies, robust and scaled manufacturing processes are required that reliably yield high amounts of high quality MSCs.

View Article and Find Full Text PDF

Gum arabic in drug delivery systems: A route-specific overview and functional insights.

Carbohydr Polym

November 2025

Department of Pharmaceutical Analysis, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, Maharashtra 400056, India. Electronic address:

Gum Arabic (GA), a naturally occurring polysaccharide, has emerged as a promising biomaterial for drug delivery systems (DDS) due to its high water solubility, emulsifying capacity, biocompatibility, and biodegradability. Its structural richness in arabinogalactan facilitates strong interactions with biomolecules, enabling the development of various drug formulations including hydrogels, nanoparticles, liposomes, and emulsions. GA-based DDS have demonstrated significant potential in enhancing the solubility of poorly water-soluble drugs, protecting bioactive compounds from degradation, and enabling sustained and controlled drug release.

View Article and Find Full Text PDF

The advancement of regenerative medicine requires robust, reproducible, and scalable platforms for the expansion and differentiation of human pluripotent stem cells (hPSCs) into specialized cells, such as cardiomyocytes. While current natural matrices like Matrigel™ suffer from batch-to-batch variability and limited tunability, synthetic scaffolds with controllable biochemical and mechanical properties could provide superior platforms for maintaining stem cell pluripotency and directing efficient cardiac differentiation. Here, we report the development and evaluation of a customizable thermoresponsive terpolymer composed of -isopropylacrylamide (NiPAAm), vinylphenylboronic acid (VPBA), and polyethylene glycol monomethyl ether monomethacrylate (PEGMMA) synthesized free-radical polymerization as a synthetic matrix for human hPSC culture.

View Article and Find Full Text PDF

Background: Neuroinflammation contributes to Parkinson's disease (PD) progression and motor dysfunction. Allogeneic human mesenchymal stem cells (allo-hMSCs) may reduce neuroinflammation and improve motor symptoms.

Objectives: To evaluate the efficacy of repeated intravenous doses of 10 × 10/kg allo-hMSCs in improving motor symptoms in patients with PD (PwP).

View Article and Find Full Text PDF

Marine polysaccharides as sustainable precursors for carbon dots and metal nanoparticles: Preparation and biomedical applications.

Bioresour Technol

August 2025

Department of Pharmacognosy, College of Pharmacy, Tanta University, El-Guish Street (Medical campus), 31527 Tanta, Egypt. Electronic address:

Marine polysaccharides (MPs), derived from a variety of marine organisms including seaweeds and crustaceans, have garnered considerable interest owing to their distinctive characteristics. MPs exhibit a variety of structural and chemical features along with versatile elemental composition, allowing for their implementation in numerous nanomaterial-based systems. Particularly, MPs have distinctive structural and chemical properties that enable them to serve as reducing and stabilizing agents in the process of nanoparticle formation.

View Article and Find Full Text PDF